{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:54:48Z","timestamp":1792061688297,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.seminhematol.2003.11.020","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:35:52Z","timestamp":1076409352000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S1","title":["Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities"],"prefix":"10.1053","volume":"41","author":[{"given":"E.Carlos","family":"Rodriguez-Merchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D","family":"Wiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Wallny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Caviglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Hvid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-E","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2003.11.020_BIB1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood.V56.6.978.978","article-title":"Anti-inhibitor coagulant complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0140-6736(93)91593-B","article-title":"Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII","volume":"342","author":"Addiego","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajh.2830210209","article-title":"Porcine factor VIII and plasmapheresis in the management of hemophiliac patients with inhibitors","volume":"21","author":"Bona","year":"1986","journal-title":"Am J Hematol"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB4","first-page":"30","article-title":"Immune tolerance for the treatment of factor VIII inhibitors\u2014Twenty years\u2019 \u2018Bonn protocol\u2019","volume":"70","author":"Brackmann","year":"1996","journal-title":"Vox Sang"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB5","first-page":"2428","article-title":"A multicenter study of recombinant factor VIII (Recombinate)","volume":"83","author":"Bray","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB6","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinte.1989.00390060103022","article-title":"The use of porcine factor VIII concentrate (Hyate: C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience","volume":"149","author":"Brettler","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of FVIII and FIX inhibitors in haemophiliac","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0887-7963(93)70126-1","article-title":"Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders","volume":"7","author":"Hedner","year":"1993","journal-title":"Transfus Med Rev"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB9","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in a patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0955-3886(98)00026-5","article-title":"Clinical use of recombinant FVIIa (rFVIIa)","volume":"19","author":"Hedner","year":"1998","journal-title":"Transfus Sci"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0022-3476(83)80032-8","article-title":"Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor","volume":"102","author":"Heisel","year":"1983","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1537-2995.1990.30790385521.x","article-title":"Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group","volume":"30","author":"Hilgartner","year":"1990","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V61.1.36.36","article-title":"The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors","volume":"61","author":"Hilgartner","year":"1983","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2516.2002.00607.x","article-title":"Orthopaedic surgery in haemophilic patients with inhibitors","volume":"8","author":"Hvid","year":"2002","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB15","series-title":"Inhibitors in Patients With Haemophilia","first-page":"169","article-title":"Elective orthopaedic surgery in haemophilia patients with high responding inhibitors","author":"Hvid","year":"2002"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB16","first-page":"118","article-title":"Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa","volume":"26","author":"Ingerslev","year":"1996","journal-title":"Haemostasis"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2000-8463","article-title":"Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors","volume":"26","author":"Ingerslev","year":"2000","journal-title":"Semin Thromb Hemost"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2516.1999.00034.x","article-title":"Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors","volume":"5","author":"Leissinger","year":"1999","journal-title":"Haemophilia"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB19","first-page":"10","article-title":"Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors","volume":"30","author":"Lozier","year":"1993","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1046\/j.1365-2141.2003.04173.x","article-title":"A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery","volume":"120","author":"Ludlam","year":"2003","journal-title":"Br J Haemtol"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199302183280701","article-title":"Recombinant factor VIII for the treatment of previously untreated patients with hemophilia. A. Safety, efficacy, and development of inhibitors","volume":"328","author":"Lusher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0025-6196(12)61340-8","article-title":"Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor","volume":"69","author":"O\u2019Marcaigh","year":"1994","journal-title":"Mayo Clin Proc"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.1999.00036.x","article-title":"Management of haemophilia in patients with high-titre inhibitors","volume":"5","author":"Penner","year":"1999","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB24","series-title":"Diagnostic Imaging in Hemophilia","first-page":"56","article-title":"Clinical and radiological evaluations of hemophilic arthropathy","author":"Pettersson","year":"1985"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB25","first-page":"S115","article-title":"Clinical experience with activated factor VII","volume":"9","author":"Roberts","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB26","series-title":"The Haemophilic Joints","year":"2003"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB27","series-title":"Musculoskeletal Aspects of Haemophilia","first-page":"136","article-title":"Orthopaedic surgery in haemophilic patients with inhibitors","author":"Rodriguez-Merchan","year":"2000"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2516.1999.00300.x","article-title":"Incidences of inhibitors in haemophilia A patients\u2014A review of recent studies of recombinant and plasma-derived factor VIII concentrates","volume":"5","author":"Scharrer","year":"1999","journal-title":"Haemophilia"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-0038-1650292","article-title":"Feasibility of using recombinant factor VIIa in continuous infusion","volume":"75","author":"Schulman","year":"1996","journal-title":"Thromb Haemost"},{"issue":"suppl","key":"10.1053\/j.seminhematol.2003.11.020_BIB30","first-page":"S97","article-title":"Experiences with continuous infusion of recombinant activated factor VII","volume":"9","author":"Schulman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0038-1642400","article-title":"Recombinant factor VIIa in a multiple surgery","volume":"71","author":"Schulman","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB32","series-title":"The Haemophilic Joints","first-page":"56","article-title":"Joint surgery in patients with inhibitors","author":"Schulmann","year":"2003"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2003.11.020_BIB34","first-page":"141","article-title":"Treatment of a high titer anti-factor-VIII antibody by continuous factor VIII administration","volume":"62","author":"White","year":"1983","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303003147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196303003147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:11:34Z","timestamp":1758521494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196303003147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":34,"alternative-id":["S0037196303003147"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.11.020","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2003.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}